Please login to the form below

Not currently logged in
Email:
Password:

Eurocine Vaccines appoints chief scientific officer and chief business officer

Anna-Karin Maltais and Emma Berglund both receive promotions

Eurocine Vaccines has appointed Dr Anna-Karin Maltais as chief scientific officer and promoted business development manager Emma Berglund to chief business officer.

Dr Maltais, who also becomes head of R&D, takes over from Professor Jorma Hinkula, who has returned to his previous position as professor at the University of Linköping in Sweden.

In her new role, Dr Maltais will oversee Eurocine's vaccines development programme, which includes Immunose – a nasal vaccine for influenza.

“Dr Maltais has extensive experience in vaccine development from both academia and industry,” said the company's CEO Hans Arwidsson.

“Her expertise in vaccine delivery and adjuvants is extremely valuable to the company and with her industry background we can run our projects with an even stronger commercial focus.”

This includes several years at Cyto Pulse Sciences, where she served as manager EU operations and then VP, corporate development.

Berglund had been in her previous position since 2009, and has prior business development experience at both Biovitrum and Avaris.

25th September 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics